BioElectronics’ Innovative Chronic Pain Therapy Nominated for “Best OTC Marketing Campaign on a Small Budget”

  • February 1st, 2016
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD. February 1, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced today that its ActiPatch® Musculoskeletal Pain Relief Therapy product received an award nomination from the OTC Bulletin, the leading international trade publication for over-the-counter pharmacy products worldwide for “Best OTC Marketing Campaign on a Small Budget”. The […]

BioElectronics Announces Publication of Breakthrough Clinical Study for Drug-free Treatment of Chronic Osteoarthritis

  • January 5th, 2016
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD. January 5, 2016 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced medical devices announced publication of a clinical study demonstrating the efficacy of ActiPatch® Therapy for knee osteoarthritis. This study further validates the positive effects of negating chronic pain central sensitization¹ by ActiPatch® noninvasive neuromodulation therapy. The technology is affordable, effective, […]

BioElectronics Announces Oxford University Sponsored Study

  • December 14th, 2015
  • News
  • 0 Comments
  • bfichter

ActiPatch® Therapy for Chronic Low Back Pain FREDERICK, MD. Dec 14, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer medical devices, today announced that Oxford University is sponsoring a clinical trial on chronic lower back pain using ActiPatch® Therapy. Chronic low back pain is a major health problem and has significant […]

BioElectronics’ ActiPatch® Pain Therapy Available at 102 Showcase Stores in Canada

  • December 7th, 2015
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD. December 7, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that its Canadian distributor, Chris-Kelly LLC, has shipped the initial stocking order to Showcase stores. Chris Russell, President, Chris-Kelly, LLC, stated, “We are excited to have a retail partner like Showcase only eight […]

BioElectronics Chairman of the Board Interview

  • December 1st, 2015
  • News
  • 0 Comments
  • bfichter

A New Audio Interview With Rick Staelin, Chairman of the Board for BioElectronics Corporation, is Now at SmallCapVoice.com AUSTIN, Texas, Dec. 01, 2015 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. (SCV) and BioElectronics Corporation (OTC Pink:BIEL), the maker of advanced consumer pain management medical devices, announced today that a new audio interview with the Company, is now […]

BioElectronics’ ActiPatch® Pain Therapy Expands Into Costco Canada

  • November 19th, 2015
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD. November 19, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that its Canadian distributor has received its initial orders for its ActiPatch® Pain Relief products from Costco’s online store, http://www.costco.ca/CatalogSearch?storeId=10302&catalogId=11201&langId=-24&refine=&keyword=actipatch. Chris Russell, President, Chris-Kelly, LLC, the Canadian distributor, stated, “This product placement in […]

Leading UK Retailer, Superdrug to market and sell ActiPatch® Pain Therapy

  • November 9th, 2015
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD. November 9, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has received an initial order for its ActiPatch® Musculoskeletal Pain Relief products from Superdrug pharmacies. Superdrug is a subsidiary of the A.S. Watson Group, the world’s largest international health and beauty […]

Chairman of BioElectronics Corporation Letter to Shareholders

  • October 22nd, 2015
  • News
  • 0 Comments
  • bfichter

The following is a letter from the Chairman of BioElectronics Corporation (OTC Pink: BIEL) to shareholders: October 22, 2015 Dear Biel Shareholders: This has been a busy last few months that has resulted in some very positive news for BIEL shareholders and I want to take a few minutes to put these events in perspective. […]

BioElectronics’ UK ActiPatch® Pain Therapy Market Expands Into 1,077 Lloyds Pharmacies and 60 Gordons Chemist

  • October 20th, 2015
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD. October 20, 2015 — BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has received initial orders for its ActiPatch® Musculoskeletal Pain Relief products for 1,077 Lloyd’s pharmacies, the second largest chain in the UK, and Gordons Chemist. ActiPatch will be on promotion in […]

BioElectronics Applauds the FDA’s Reclassification of Nonthermal Shortwave Therapy Devices

  • October 14th, 2015
  • News
  • 0 Comments
  • bfichter

FREDERICK, MD. October 14, 2015 — BioElectronics Corporation (OTC Pink: BIEL), maker of consumer medical electronics products for pain management endorsed the U.S. Food and Drug Administration’s final rule 890.5290 on nonthermal pulsed shortwave devices published today in the Federal Register. “I am pleased the agency has completed this step in streamlining the regulatory requirements […]